Reduction In Abdominal Circumference Research Articles

Effects of a physical exercise programme on bodyweight, body condition score and chest, abdominal and thigh circumferences in dogs

BackgroundResearch on the effects of physical exercise on canine body composition is limited. The aim of this study was to investigate the effects of a physical exercise programme on bodyweight, body condition score (BCS) and chest, abdominal and thigh circumferences in dogs. Twenty-one healthy dogs of different breeds exercised together with their owners during an eight-week programme consisting of jogging and strength exercises. Standardised measurements were performed in triplicates with a measuring tape on standing dogs. Chest circumference was measured at three anatomical locations, abdomen at two and thigh at one. Data on bodyweight, BCS (9-point scale) and circumferences were analysed with mixed model repeated measures analyses to evaluate changes after the programme and effects of target distance.ResultsSeven dog owners choose a target distance of 2 km and 14 owners choose 5–10 km. Mean BCS decreased (P = 0.007) after the programme (5.1 ± 0.9 vs. 4.7 ± 0.6) but there was no effect of target distance. Almost all chest and abdominal circumference measurements decreased (P ≤ 0.007) with the 2 km group driving the reduction in chest circumference and the 5–10 km group driving the reduction in abdominal circumference. In contrast, thigh circumference (28.8 ± 0.4 vs. 30.2 ± 0.4) increased (P = 0.007) while bodyweight was maintained. There were positive correlations between BCS and abdominal/chest ratios before and after the programme (Pearson correlation; R square ≤ 0.43, P ≤ 0.0012) but the mean ratio remained constant.ConclusionsResults indicated a redistribution between total body fat and muscle mass in body composition of normal weight to slightly overweight dogs after the physical exercise programme. The use of bodyweight alone was not a reliable evaluation method to complement the BCS assessment. However, repeated measurements of chest, abdominal and thigh circumference might aid in the assessment of body composition in dogs performing physical exercise. Further research should include a control group and objective evaluations of total body fat and lean mass, in order to investigate the effectiveness of physical exercise as a freestanding method for decreasing BCS and increasing muscle mass in overweight dogs.

Radiofrequency and Electrical Muscle Stimulation: A Synergistic Treatment That Achieves Lipolysis and Circumferential Waist Reduction in Noninvasive Body Contouring.

Surgeons and providers in aesthetic medicine seek noninvasive devices that can be utilized for safe, efficient, and effective body contouring. Patient demand has propelled the development of novel devices that can simultaneously improve skin laxity, adipolysis along with stimulation of muscle hypertrophy. To determine the efficacy of body contouring after 3 treatments using the noninvasive Transform (InMode, Lake Forest, CA) device. A prospective, multicenter study was performed. Outcomes evaluated include: standardized caliper and ultrasound measurements of abdominal skin/soft-tissue thickness, waist circumference, histologic evaluation, patient comfort, and satisfaction assessments. Forty-four patients were successfully enrolled in the study and completed the series of 3 treatments which involved combined electrical muscle stimulation (EMS) and noninvasive bipolar radiofrequency (RF). Abdominal ultrasound measurements reveal a decrease in soft-tissue thickness (average 3.1 mm; P = .001), there was a significant decrease in caliper measurements of periumbilical skin thickness (P < .003), and the average reduction of abdominal circumference was 1.9 cm (P < .0001) 3 months after the treatment series. Histology confirmed subcutaneous adipolysis without damaging the dermal layer. Patients reported a high degree of satisfaction with the overall result (P = .003) and that each of the 3 treatments were progressively more comfortable (P < .005). This study demonstrates that a series of simultaneous noninvasive RF with EMS treatments to the abdomen decreases subcutaneous soft-tissue thickness of the treated area. These comfortable treatments ultimately result in a high degree of patient satisfaction at 3 months.

Results on reduction of subcutaneous adipose tissue using a novel body contouring system based on microwave technology

Over the past decade, the body shaping market has seen steady growth. In order to improve procedures to reduce localized fat deposits, a novel method specifically targeting subcutaneous adipose tissue was developed. The objective of this study is to demonstrate that a novel microwave device with a frequency of 2.45 GHz achieves visible results with greater safety and consistency in reducing adipose tissue. In all, 19healthy patients (10women and 9men; age 24-55years, average age 39years) and visible abdominal fat received three microwave treatment sessions (each 4weeks apart) using the new Onda Plus Body Shaping System (DEKA, Italy). The device uses a handpiece that generates microwaves with a frequency of 2.45 GHz and integrated cooling for optimal patient comfort during treatment. An appropriate treatment protocol was established and applied for approximately 10min in each treatment area. Before the start of treatment, informed consent and photo release forms were signed by all patients. Before each treatment session, the following were collected: body weight, height, waist circumference, and photographs of the area to be treated. All areas to be treated were premarked with a white skin marker pen while standing. Obese patients and those in whom fat deposits were distributed over the entire body or whose skin was in a state of irreversible flaccidity were excluded. A blood test was performed for each patient, both before the start of treatment (T0) and at the end of the entire treatment protocol (T3). All patients met the inclusion/exclusion criteria of the study and signed an informed consent form. The 19healthy adults were divided into three groups according to the size of the abdominal fold (pinch): group1 comprised 4patients with a pinch greater than 4.5 cm, group2 had 10patients with a pinch of 2.5-4.5 cm, and group3 had 5patients with a pinch less than 2.5 cm. At the 3‑month follow-up, the clinically measurable reduction in abdominal circumference was 3.80 ± 1.21 cm in all patients. The microwave-based body contouring system was shown to be safe and effective to reduce abdominal circumference. No severe pain or noticeable discomfort was reported during any of the treatment sessions.

Indonesian Brown rice improves obesity parameters and dysbiosis of gut microbiota

BACKGROUND: Brown rice contains nutrients that significantly reduce the incidence of obesity. This study aimed to investigate the effect of brown rice as a functional food on the reduction of obesity incidence through the pathways of gut microbiota dysbiosis. METHODS: In this study, we used white rats (Rattus norvegicus albus), which were divided into five groups, i.e., Normal, High fructose feed diet (HFFD), HFFD + Brown rice (BR) I, HFFD + BR II, HFFD + BR III. The parameters were SCFA concentration, FFAR3 expression, and Firmicutes– Bacteroidetes ratio. RESULTS: The rats fed HFFD + BR III diet with a high intake of brown rice resulted in a greater reduction in abdominal circumference. The group of rats fed the HFFD had a higher BFI than the other rats. The brown rice intervention reduced the Lee index, a higher concentration of short-chain fatty acid (SCFA), and led to a higher reduction in Firmicutes– Bacteroidetes ratio. The brown rice intervention also increased the FFAR3 expression in the rat ileal L cells. CONCLUSIONS: Brown rice has significant benefits for reducing obesity, as evidenced by the improvement in the abdominal circumference, Lee index, and BFI through the improvement of intestinal dysbiosis and increase in SCFA concentration and FFAR3 expression.

Effect of Rapid Body Weight Loss on Balance and Functional Mobility in Obese Individuals after Laparoscopic Adjustable Gastric Banding Operation

The purpose of this study was to evaluate the effect of rapid weight loss on static balance and functional mobility among excessively obese patients undergoing Laparoscopic Adjustable Gastric Banding (LAGB) surgery. Subjects (8 females; BMI &amp;gt;35 kg/m2) underwent baseline measurements before LAGB surgery, followed by subsequent evaluations at 6 weeks, 12 weeks, and 24 weeks during the follow-up appointments. During each evaluation, various assessments were conducted, including measurements of anthropometry such as body weight, height, hip and waist circumference, as well as functional tests for static balance, 10-meter walk, and timed get-up-and-go. There were statistically significant changes in weight, BMI, waist circumference, hip circumference, abdominal circumference, waist-hip ratio, static sway eyes open, timed up-and-go, 10-meter walk, and steps in 10-meter walk test values (p&amp;lt;0.001) between the baseline and the postoperative measurements. However static sway values under eyes closed condition were not statistically significant. In the 24-week follow-up, the weight loss, reduction in abdominal circumference, increase in walking speed against time and step count, and recovery in functional movements were shown to persist. Also, reduction in static balance surface oscillation confirmed the improvement of balance control.

A Study of Lifestyle Modifications with and Without Metformin in Prediabetic Subjects

Purpose: Prediabetes is a stage in the natural history of impaired glucose metabolism rather than as a distinctive clinical entity. The primary objective was to compare the effect of lifestyle modifications (LSMs) with and without metformin in prolonging the onset of diabetes mellitus in prediabetics. Materials and Methods: This study is an open label, parallel group comparative study conducted from 2016 to 2020. One hundred and four prediabetic subjects were assigned to two groups: group I (51) LSM and group II (53) metformin 500 mg along with LSM. Baseline investigations included fasting blood sugar (FBS), post-prandial blood sugar (PPBS), HbA1c, and lipid profile, followed up for 12 months. Results: The baseline parameters were comparable between the groups. In both the groups, there was a significant reduction in abdominal circumference, total cholesterol, triglycerides, low-density lipoprotein, FBS, PPBS, and HbA1c between baseline and 1 year. There was no significant difference between groups I and II in reduction of all the above-mentioned parameters. The outcomes of prediabetic subjects after 1 year of treatment in both the groups were comparable. Only one (2.1%) subject had more than 126 mmHg FBS in the LSM group. The adverse effects observed were dizziness, nausea, flatulence, myalgia, abdominal pain, and heart burn, which were mild to moderate in intensity and in most patients it subsided with time. Conclusion: LSM alone was equivalent to LSM along with metformin in effective control of blood sugars. Lipid profile and weight may be significantly reduced.

Application Effect of Somatostatin Combined with Transnasal Ileus Catheterization in Patients with Acute Intestinal Obstruction and Advanced Gastric Cancer.

Objective: To explore the application of somatostatin combined with nasal plug catheterization in patients with advanced gastric cancer and acute intestinal obstruction. Methods. This study included 94 cases of patients with acute intestinal obstruction and advanced gastric cancer, and according to the length of hospital stay, the patients were randomly divided into two groups: the control group and the study group, with 47 cases in each group. Based on the observations made by the team in the control group given somatostatin combined treatment, we observed two groups of patients with gastrointestinal function, serum index, quality of life, therapeutic effect, and adverse reactions. Results. Abdominal distention, abdominal pain duration, and normal exhaust time were significantly shorter in the study group than in the control group. The study group was higher than the control group in terms of gastrointestinal decompression volume, drainage volume, and abdominal circumference reduction within 24 hours (P < 0.05). After treatment, the levels of CRP, IgA, LPS, and FABP were lower than before, and the levels of CRP, IgA, LPS, and FABP in the former group were much lower than those in the latter group (P < 0.05). Compared with before treatment, the former GIQLI scale score was significantly higher than the latter (P < 0.05). After treatment, the efficiency is much higher than the latter (P < 0.05). After treatment, the former significantly lowers the incidence of postoperative complications of the latter (P < 0.05). Conclusion. For patients with advanced gastric cancer and acute intestinal obstruction, it is safe and feasible to use somatostatin combined with transnasal intestinal obstruction catheterization to restore gastrointestinal function, improve inflammatory response, and promote the improvement of quality of life with high safety and feasibility.

A novel nonfocused pulsed ultrasound technology for noninvasive circumference reduction.

There is a continuously growing demand for circumference reduction and body shaping technologies, with an overwhelming preference for non-invasive, pain-free procedures. This paper presents a novel body contouring device which uses pulsed, vacuum-assisted non-focused ultrasound. To evaluate the clinical safety and efficacy of the vacuum-assisted acoustic wave technology for circumference reduction of the abdominal region. Eighteen healthy women with a body mass index under 25 underwent four 20-min fat reduction treatments in the abdominal region, at 1-week intervals. Efficacy was evaluated by the change in abdominal circumference up to 12 weeks post treatment relative to baseline and by comparison of before and after photos by two blinded evaluators. Subjects rated their satisfaction with the treatment procedure and outcomes. Safety was evaluated by adverse events, local skin reaction, and pain assessments. 1 week after the final session, the mean reductions in abdominal circumference measured 5.4± 2.6cm. At 1month after the last session, the cumulative reduction in circumference was 5.8± 3.2cm. Measurements take at 3months after the last treatment showed abdominal circumferences decrease of an average 5.2± 3.1cm relative to baseline measures. All patients reported a painless procedure and there were no treatment-induced severe adverse events. Most patients reported a positive change in body contour, with all subjects saying they would highly recommend the treatment to others. Assessments performed by blinded evaluators ranked six cases as very to extremely improved and an additional seven cases as somewhat improved. No dramatic weight fluctuations were recorded. This study demonstrates that a four-treatment course with an acoustic wave ultrasound applicator with 1-week intervals, leads to a significant reduction in abdominal circumference, lasting up to at least 3months with no pain or side effects reported.

Effect of newer antihyperglycemic drugs on liver steatosis indices in patients with diabetes and obesity

Aim To assess the efficacy of sodium–glucose cotransporter-2 inhibitor (SGLT2i) and glucagon-like peptide-1 receptors agonist (GLP-1RA) therapy on liver steatosis measured by fatty liver index (FLI) and hepatic steatosis index (HSI) at 26 weeks in outpatients with diabetes and obesity. Methods Observational, prospective, multicenter study. Patients with steatosis determined by FLI (values <30 rule out and >60 indicate steatosis) and HIS (values <30 rule out and >36 indicate steatosis) who received combination therapy were included. Patients were stratified into three groups according to the sequential order of treatment. We used robust statistical methods. Results In our final report we included 174 patients (58.6% males), mean age 61.9 (10) years. Baseline body mass index, waist circumference and weight were 36.5 (6.8) kg/m2, 117.5 (15.1) cm and 99.4 (20.5) kg, respectively. One hundred percent of patients had altered biomarkers of fatty liver scores (FLI 96 [13] and HSI 49.2 [8.5]). At 26 weeks, significant reductions in FLI (−4.5 [95% CI 3.5–5.9] p < .001) and HSI (−2.4 [95% CI 1.6–3.2] p < .001) were found in the total sample and pre-specified treatment and FLI cut-off point subgroups. Conclusion Our results show a beneficial effect of the combination of GLP-1RAs plus SGLT2is on liver steatosis that goes beyond glucose control, and it is related mainly to weight loss, a decline in biomarkers and reductions in abdominal circumference. For many patients, early detection is essential to improving outcomes in NAFLD and could allow us to select the most efficient treatment options.

English

The occurrence of chronic and degenerative diseases, such as obesity, diabetes, cardiovascular disease (CVD), and cancer is increasing sharply. In the last years, there has been an increase in interest in the consumption of foods with functional properties that are related to weight loss and disease prevention. For these reasons, this study aimed to evaluate the effects of flour prepared with grains and fruits on the metabolic profile of Wistar rats. Female rats were randomly divided into four groups: G1: control group; G2: Animals that received condensed milk and sugar; G3: Animals that received food supplemented with a mixture of powdered grains and fruits; G4: Animals that received condensed milk, sugar and rat food supplemented with a mixture of powdered grains and fruits. The authors results showed that the use of the flour of grains and fruits promoted a significant reduction in abdominal circumference, visceral fat, and triglycerides levels in the animals from G3 compared with G1. However, the use of the flour&nbsp;of grains and fruits can be beneficial in association with a balanced diet. When the association is carried out at the same time that there is the consumption of foods rich in sugars, the beneficial effects was not observed. Key words: Obesity, grains, fruits, cardiovascular disease. &nbsp;

Traditional weight loss and dukan diets as to nutritional and laboratory results

Traditional weight loss and dukan diets as to nutritional and laboratory results

Abdominal Laser Lipolysis Using a Microprocessor-Controlled Robotic Arm With Noncontact Heating and Cooling.

A novel FDA-cleared device uses a 1064-nm laser to noninvasively induce apoptosis for lipolysis of subcutaneous abdominal fat while maintaining comfortable skin temperatures with a proprietary jet cooling system (eon; Dominion Aesthetic Technologies, Inc., San Antonio, TX). A programmable articulated robotic arm moves the treatment head without any subject contact, maintaining an appropriate 3-dimensional treatment path, compensating for patient movement. The goal of this prospective, single center, open-label study was to demonstrate the safety and effectiveness of this device for reducing subcutaneous abdominal fat when operated with an updated power delivery curve. Male and female subjects with Fitzpatrick skin types I to VI (N = 26) were treated. Four abdominal zones up to 150 cm2 each, customized in size and location for body habitus, were treated. Each zone underwent a single 20-minute treatment session. Follow-up visits occurred after 6 and 12 weeks. A standardized protocol was used to obtain ultrasound measurement of subcutaneous abdominal fat thickness, abdominal circumference, reported patient satisfaction and digital images. The mean treatment area was 378.5 cm2. At Week 12, there was a 21.6% or 6.3 mm mean reduction in abdominal subcutaneous fat thickness and a 4.1-cm (1.6-inch) mean reduction in abdominal circumference. Most subjects (84.6%) were satisfied or very satisfied with their results. The mean pain score was 2.5 on an 11-point ordinal scale. There were no nonresponders. Only 2 adverse events were noted: mild transient erythema (n = 1, 3.8%) and localized subcutaneous firmness (n = 1, 3.8%) which resolved without intervention within 12 weeks. This contact-free device is safe and effective for reducing subcutaneous abdominal fat and represents an improvement on the prior treatment protocol.

Acupoint catgut-embedding therapy as promising treatment for non-alcoholic fatty liver disease

To investigate the effect of acupoint catgut-embedding therapy on non-alcoholic fatty liver disease (NAFLD). Twenty-three participants were subjected to acupoint catgut-embedding therapy for 3 sessions. The second session was performed one month after the first session and the third session two months after the second session. Three months after the third session of catgut-embedding therapy, the patients were subjected to fibroscan analysis. A total of 20 acupoints were selected in three sessions. Same acupoints were selected for all the patients at the same session but different points were selected at different sessions. Of the 23 participants, 5 cases showed significant improvement and 8 cases showed moderate improvement as the steatosis stage was reduced by 1 or 2 degrees. The whole group showed significant improvements in terms of patient score, fat percentage, NAFLD steatosis stage, weight loss and abdominal circumference reduction after acupoint catgut-embedding therapy (all P<0.05). The acupoint catgut-embedding therapy can significantly improve the important factors in patients with NAFLD.

Clinical usefulness of cell-free and concentrated ascites reinfusion therapy (CART) in combination with chemotherapy for malignant ascites: a post-marketing surveillance study.

Cell-free and concentrated ascites reinfusion therapy (CART) has been suggested to be able to treat malignant ascites more safely and effectively with chemotherapy because of its ability to retain serum protein and albumin. Although the characteristics of cancer types and CART and the clinical implications of combination therapy with antitumor agents are becoming widespread, there are limited reports on its efficacy and complications. In this prospective observational national post-marketing study, 128 patients with malignancies received 300 CART sessions at 22 centers. After excluding other malignancies, the patients were divided into four groups: gynecological malignancies with chemotherapy (GYC+; 18 cases and 36 times) and without chemotherapy (GYC-; 35 cases and 52 times), and gastrointestinal malignancies with chemotherapy (GIC+; 8 cases and 16 times) and without chemotherapy (20 cases and 58 times). There were significant reductions in the body weight in all groups and significant reductions in abdominal circumference and significant improvements in the diet and Eastern Cooperative Oncology Group performance status only in the GYC+ group. The total serum protein and albumin increased significantly in all groups, except for the GIC+ group, before and after CART. There was no significant difference in the presence or absence of antitumor medication. With CART, there were differences in the improvement of the clinical symptoms between malignancy groups. The combination of CART and antineoplastic agents may be as safe as CART alone in cases of exudative malignant ascites.

Sculpt plaster therapy for abdominal circumference reduction

Sculpt plaster therapy for abdominal circumference reduction

Positive psychological characteristics in patients with metabolic syndrome associated with prospective changes in diet and anthropometric factors.

The prevalence of metabolic syndrome (MetS) is increasing worldwide, and diet therapy plays a key role in treating this disease. Since most patients show difficulties in adhering to nutritional interventions, research on the association of positive psychological characteristics with greater engagement in physical health is relevant to this field. The present study aimed to evaluate the association between positive psychology attributes (optimism, hope, self-esteem, positive/negative affect and life satisfaction) and changes in diet quality and anthropometric parameters of individuals with MetS who received nutritional counseling. The study assessed 63 patients at a nutrition outpatient clinic. Anthropometric parameters and 24-hour food recall data (for evaluation of the Brazilian Healthy Eating Index—Revised–BHEI-R) were collected at the first visit and subsequent return visit (on average five months later). Psychological data were collected at the first visit using validated and standardized scales. The results were adjusted in relation to the depression scores of the patients, which were evaluated using the Beck Depression Inventory-II (BDI-II). Changes in anthropometric factors and in the BHEI-R were assessed, and their associations with the psychological attributes were investigated. The results indicated that positive affect and hope were associated with improvement in the BHEI-R scores (Cohen effect sizes -0.65 and -0.58; p = 0.012 and 0.025, respectively). A significant association was also observed between optimism and a reduction in abdominal circumference (Cohen effect size 0.56; p = 0.031). The associations remained significant even after adjusting for the BDI-II scores (p = 0.022, p = 0.037 and p = 0.05, respectively). No statistically significant associations were observed for the other attributes assessed.The study suggests that some attributes may have a greater influence on the nutritional treatment of MetS and that future studies should be conducted in order to enable effective multidisciplinary interventions to treat MetS.

Long-Term Effects of Continuous Positive Airway Pressure (CPAP) Therapy on Obesity and Cardiovascular Comorbidities in Patients with Obstructive Sleep Apnea and Resistant Hypertension-An Observational Study.

Background: We sought to investigate whether long-term continuous positive airway pressure (CPAP) treatment in patients with obstructive sleep apnea (OSA) and resistant hypertension (RHTN) could attenuate the cardiovascular disease risk by lowering their body-mass index (BMI). Methods: This was a long-term observational study of RHTN patients diagnosed with OSA. Patients were evaluated with polysomnography initially and after a mean follow-up period of four years. The patients were divided into two groups based on their compliance to CPAP therapy. Results: 33 patients (aged 54.67 ± 7.5, 18 men, 54.5%) were included in the study, of which 12 were compliant to CPAP therapy. A significant reduction in BMI at follow-up was noted in patients compliant to CPAP therapy (1.4 ± 3.5 vs. −1.6 ± 2.5, p = 0.006). We also noted a large effect size reduction in abdominal circumference at follow-up in the CPAP group. At follow-up evaluation, the mean heart rate (b/min) was lower in the CPAP group (58.6 ± 9.5 vs. 67.8 ± 7.8), while arrhythmia prevalence increased between initial (28.6%) and follow-up (42.9%) evaluation with an intermediate effect size in non-compliant patients. Conclusions: In our cohort of OSA patients with RHTN, long-term adherence to CPAP therapy was associated with weight loss and improvement in cardiac rhythm outcomes.

Short term escalating administration of large amount of sneha does not increase blood lipids

Vardhamana snehapana or shodhana sneha is classical Ayurvedic treatment in which escalating dose of sneha or ghee is administered for utkleshana (precipitation and dilution) of morbid doshas in body. Due to snehana and swedana, doshas get separated from dhatus, channelized towards koshtha, from where they can be easily and safely removed by appropriate cleansing therapy or shodhana like vamana (emesis) or virechana (purgation). Since this type of snehana requires administration of large amount of sneha or ghee there is fear that patients may experience increase in harmful lipids. The present study examined the effect of vardhamana snehapana on relevant physical and physiological parameters in normal individuals before and after samyak snehana and shodhana. Vardhamana snehapana was administered in healthy individuals according to agni and koshtha to achieve samyak snigdha lakshanas (symptoms of proper oleation).We assessed parameters of vardhamana snehapana in all individuals including samyak snigdha lakshanas, jeeryamana lakshanas, total quantity of sneha consumed. Effect of vardhamana snehapana on weight, abdominal circumference and lipid profile were measured before and after vardhamana snehapana. Statistical significance of results were quantitated by paired t test. After vardhamana snehapana, 16 out of 29 volunteers showed a significant weight loss of > 2 kg (p < 0.0001). The remaining 13 volunteers showed less but significant weight loss <2 kg (p < 0.0001). Notably, all 29 volunteers showed a significant reduction in abdominal circumference (p ≤ 0.0006) after vardhamana snehapana. Although vardhamana snehapana did not significantly alter levels of total cholesterol, HDL, and LDL, it did cause a significant reduction in triglycerides (p = 0.009) and VLDL (p = 0.005) in all 29 volunteers. Vardhamana snehapana is responsible for precipitation of doshas and does not cause brumhana (Nourishment of dhatus or body elements). Importantly, this treatment did not negatively affect health of any of the volunteers. Notably, Vardhamana snehapana caused different degrees of statistically significant reduction in body weight, abdominal circumference, and levels of specific lipids (triglycerides and VLDL) in these 29 volunteers. These encouraging results could be due to the composition and metabolism of the pure cow's ghee used for vardhamana snehapana treatment in this study.

Pilot-Testing of "Healthy Body Healthy Mind": An Integrative Lifestyle Program for Patients With a Mental Illness and Co-morbid Metabolic Syndrome.

Background: Metabolic syndrome and co-morbid physical health conditions are highly prevalent in people with a mental illness. Modifiable lifestyle factors have been targeted to improve health outcomes. Healthy Body Healthy Mind (HBHM) program was developed to provide an integrated evidence-based program incorporating practical diet and exercise instruction; alongside meditation and mindfulness strategies, and comprehensive psychoeducation, to improve the physical and mental health of those with a mental illness.Methods: We report on two data points: (1) Qualitative data derived from the first HBHM program (version 1) exploring its utility and acceptance according to patient feedback; (2) Biometric and mental health data collected on the modified and enhanced 12-week HBHM program (version 2) involving a pilot of 10 participants. Mental and physical health outcomes, weight, abdominal circumference, fasting glucose, cholesterol, and triglycerides were measured at program entry and completion.Results: Qualitative data from HBHM version 1 provided valuable feedback to redevelop and enhance the program. At the end of the HBHM (version 2) 12-week program, a significant mean weight loss of 2 kg was achieved, p = 0.023. There was also a significant reduction in abdominal circumference (mean = 2.55 cm) and a decrease in BMI of almost one point (mean = 0.96 kg/m2), p = 0.046 and p = 0.019, respectively. There were no significant changes in mental health measures or on any other biometrics.Conclusion: Pilot data from the HBHM program found significant reductions in weight and abdominal obesity. The HBHM program could benefit from further modifications, and study replication is required using a controlled design in a larger sample.

Características clínicas, bioquímicas y complicaciones de los pacientes sometidos a la cirugía bariátrica con 18 meses de seguimiento en un hospital de alta complejidad

Objective: To determine the clinical and biochemical characteristics, as well as the complications of bariatric surgery in 18 months of follow-up in a highly complex hospital, between 2012 and 2016. Methods: A descriptive, retrospective study was performed in patients undergoing bariatric surgery (gastric by-pass or gastric sleeve), where the clinical and biochemical characteristics, as well as the complications and post-intervention changes were evaluated in a before-after analysis. Results: Fifty nine patients were studied, 89.8 % were women, with an average age of 41.8 ± 10,8. The 76,3 % underwent gastric bypass and 23.7 % gastric sleeve. The mean percentage of weight lost at 18 months was 81 % ± 22. There was a significant reduction in abdominal circumference. 100 % of patients experienced changes in multimorbidities Conclusion: We found a significant decrease in the percentage of body mass index. In addition, a change in comorbidities and modification in biomarkers was observed. There was no post-operative mortality 18 months after surgery.